Tetrahydrofolic acid ( THFA), or tetrahydrofolate, is a folic acid derivative.
Many bacteria produce tetrahydrofolic acid via dihydropteroate. Humans lack the enzymes to do this, thus molecules that shut down these enzymes are effective antibacterial compounds. For example, sulfonamide antibiotics competitively binds the active site of dihydropteroate synthetase, excluding the binding of the dihydropteroate precuror, 4-aminobenzoic acid (PABA).
Methotrexate acts on dihydrofolate reductase, like pyrimethamine or trimethoprim, as an inhibitor and thus reduces the amount of tetrahydrofolate made. This may result in megaloblastic anemia.
Tetrahydrofolic acid is involved in the conversion of formiminoglutamic acid to glutamic acid; this may reduce the amount of histidine available for decarboxylation and protein synthesis, and hence the urinary histamine and formiminoglutamic acid may be decreased.
Image:Dihydrofolic acid.svg|Dihydrofolic acid
Image:5,10-methylenetetrahydrofolic acid.svg|5,10-Methylenetetrahydrofolic acid
Image:10-formyl-tetrahydrofolic acid.svg|10-Formyltetrahydrofolic acid
|
|